Annovis Bio, Inc. (ANVS) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $16.85M | +81.0% |
| 2024 | $9.31M | +220.1% |
| 2023 | -$7.75M | -127.4% |
| 2022 | $28.32M | -36.3% |
| 2021 | $44.49M | +490.0% |
| 2020 | $7.54M | +187.9% |
| 2019 | -$8.58M | -12.9% |
| 2018 | -$7.59M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $16.85M | +81.0% |
| 2024 | $9.31M | +220.1% |
| 2023 | -$7.75M | -127.4% |
| 2022 | $28.32M | -36.3% |
| 2021 | $44.49M | +490.0% |
| 2020 | $7.54M | +187.9% |
| 2019 | -$8.58M | -12.9% |
| 2018 | -$7.59M | — |